Literature DB >> 8462212

Preoperative localization of parathyroid carcinoma using Tc-99m MIBI.

M T Kitapçi1, G Tastekin, M Turgut, B Caner, A Kars, I Barista, C Bekdik.   

Abstract

A patient with parathyroid cancer is presented who underwent Tc-99m MIBI scintigraphy. The Tc-99m MIBI image demonstrated increased accumulation of activity at the lower pole of the left thyroid lobe which was later confirmed as a parathyroid cancer. Uptake by parathyroid cancer must be kept in mind as a cause of increased Tc-99m MIBI accumulation when a disease is in question in the thyroid or parathyroid gland.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462212     DOI: 10.1097/00003072-199303000-00007

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  Thymic carcinoid and parathyroid hyperplasia detection with 99mTc-MIBI men type 1.

Authors:  C Marí; J León; J Farrerons; X Matis-Guiu; A Tembl; J C Martin; A Flotats; L l Bernà
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

2.  Non-secreting atypical parathyroid adenoma.

Authors:  K Poppe; M Pipeleers-Marichal; P Flamen; A Bossuyt; J Lamote; L Vanhaelst; B Velkeniers
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

3.  Visualisation of a paraganglioma by technetium-99m-sestamibi scintigraphy.

Authors:  M Piga; G P Farina; G L Loi; A Serra; M A Calia; L Lai; G Zucca; S Mariotti
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

Review 4.  Technetium-99m methoxyisobutylisonitrile localizes an ectopic ACTH-producing tumour: case report and review of the literature.

Authors:  H Jacobsson; G Wallin; S Werner; S A Larsson
Journal:  Eur J Nucl Med       Date:  1994-06

Review 5.  Is there a consensus between clinical practice guidelines for conventional and molecular nuclear medicine studies in parathyroid pathology?

Authors:  Marylin Acuña Hernandez; Liset Sanchez Orduz; Uvi Cancino Ramos; Paola Vallejo Armenta; Leonardo Cadavid Blanco
Journal:  Ann Nucl Med       Date:  2021-07-24       Impact factor: 2.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.